FdaApplication
ANDA 201851
Identifiers
- fda_app_no: ANDA201851
Properties
| Property | Value |
|---|---|
| applicant_name | SAGENT PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2020-11-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CISATRACURIUM BESYLATE | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE;INJECTION |
1 product